Pharmacotherapy for anxiety disorders and comorbid alcohol dependency
dc.contributor.author | Wilson D. | |
dc.contributor.author | Ipser J.C. | |
dc.contributor.author | Stein D.J. | |
dc.date.accessioned | 2011-05-15T16:01:27Z | |
dc.date.available | 2011-05-15T16:01:27Z | |
dc.date.issued | 2008 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Review | |
dc.identifier.citation | Cochrane Database of Systematic Reviews | |
dc.identifier.citation | 4 | |
dc.identifier.issn | 1469493X | |
dc.identifier.other | 10.1002/14651858.CD007505 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/11985 | |
dc.subject | benzodiazepine | |
dc.subject | lorazepam | |
dc.subject | mirtazapine | |
dc.subject | naltrexone | |
dc.subject | placebo | |
dc.subject | pregabalin | |
dc.subject | alcohol consumption | |
dc.subject | alcoholism | |
dc.subject | anxiety disorder | |
dc.subject | cognitive therapy | |
dc.subject | comorbidity | |
dc.subject | detoxification | |
dc.subject | disease severity | |
dc.subject | drug effect | |
dc.subject | drug tolerability | |
dc.subject | human | |
dc.subject | review | |
dc.subject | treatment response | |
dc.subject | unspecified side effect | |
dc.title | Pharmacotherapy for anxiety disorders and comorbid alcohol dependency | |
dc.type | Review |